Electroresponsive materials are promising carriers for developing drug delivery systems (DDSs) with excellent spatial, temporal, and dosage control over drug release. Current electroresponsive systems use high voltages (2-25 V), are not bioresorbable, or use materials with unknown long-term biocompatibility. We report here a nanocomposite film that is resorbable, electroresponsive at low voltages (<-2 V), and composed of entirely FDA-approved materials. Our DDS is based on poly(methyl methacrylate-co-methacrylic acid), commercially marketed as Eudragit S100 (EGT), which has pH-dependent aqueous solubility. Nanometric films of drug-loaded EGT were designed, synthesized, and coated with a protective layer of chitosan. We hypothesized that electric stimuli would cause local pH changes on the working electrode, leading to pH-responsive dissolution of EGT with concomitant drug release. Our results confirm that local pH changes impart electroresponsive release behavior to the films. Furthermore, drug release scales linearly with voltage, current, and time. The generalizability of the system is shown through the release of several molecules of varying hydrophobicity, pKa, and size, including fluorescein (free acid and sodium salt), curcumin, meloxicam, and glucagon. The ability to modulate drug release with the applied stimulus can be utilized to design minimally invasive drug delivery devices based on bioresorbable electronics. Such devices would allow for personalized medicine in the treatment of chronic diseases.
Bibliographical noteFunding Information:
DS thanks the Winston Chen Stanford Graduate Fellowship and the Center for Molecular Analysis and Design at Stanford University for funding. RM thanks Stanford Institutes of Medicine Summer Research Program for providing a summer research opportunity. KM is grateful to the American Heart Association Innovative Research Grant #16IRG27330012.
© The Royal Society of Chemistry.